Μετάβαση στο περιεχόμενο

ΕτικέταAgios Pharmaceuticals

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

  Shares of Agios Pharmaceuticals jumped this morning after the Cambridge, Mass.-based company said the U.S.Food and Drug Administration (FDA) approved its oral leukemia treatment Tibsovo (ivosidenib). It’s the second approval for the company in … Continue Reading Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year